Screening colonoscopy and fecal occult blood testing practice patterns: A population-based survey of gastroenterologists

Journal of Clinical Gastroenterology

Volumn 42, Issue 10, 2008, Pages 1089-1094

  Rossi, Federico ^a   Sosa, Julie Ann ^a   Aslanian, Harry R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colon cancer; Colonoscopy; FOBT

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DUODENOSCOPY; FAMILY HISTORY; FEMALE; HEALTH SURVEY; HUMAN; MALE; MEDICAL PRACTICE; OCCULT BLOOD TEST; PHYSICIAN; PRIORITY JOURNAL; CLINICAL PRACTICE; COLORECTAL TUMOR; EPIDEMIOLOGY; GASTROENTEROLOGY; MASS SCREENING; METHODOLOGY; OCCULT BLOOD; PRACTICE GUIDELINE; STATISTICS;

COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; GASTROENTEROLOGY; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; MALE; MASS SCREENING; OCCULT BLOOD; PHYSICIAN'S PRACTICE PATTERNS;

EID: 58149232621     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181599bfc     Document Type: Article

References (22)

1. US Preventive Services Task Force. Screening for colorectal cancer in adults at average risk: recommendations and rationale. Ann Intern Med. 2002;137:129-131.
2. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53:27-43.
3. Pignone M, Rich M, Teutsch SM, et al. Screening for colorectal cancer in adults at average risk: summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137: 132-141.
4. Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc. 2006;63:546-557.
5. Winawer SJ, Fletcher RH, Rex DK, et al. American Gastroenter-ological Association. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544-560.
6. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2000;95: 3053-3063.
7. Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology. 2004;127: 1670-1677.
8. Seeff LC, Nadel MR, Klabunde C, et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer. 2004;100: 2093-2103.
9. Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med. 2003;115:129-133.
10. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24-28.
11. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-1371.
12. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale- update based on new evidence. Gastroenterology. 2003;124:544-560.
13. Ahlquist DA. Fecal occult blood testing for colorectal cancer. Can we afford to do this? Gastroenterol Clin North Am. 1997;26:41-55.
14. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force [review]. Ann Intern Med. 2002;137:96-104.
15. Folio Physician Directory. Connecticut and Rhode Island. Hyannis, MA: Folio Associates; 2006.
16. Finkelstein S, Bini EJ. Annual fecal occult blood testing can be safely suspended for up to 5 years after a negative colonoscopy in asymptomatic average-risk patients [abstract]. Gastrointest Endosc. 2005;61:AB250.
17. American Medical Association. Physician Characteristics and Distribution in the US, 2005. USA: AMA Press; 2005.
18. Bampton PA, Sandford JJ, Cole SR, et al. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology. Gut. 2005;54:803-806.
19. Rex DK, Petrini JL, Baron TH, et al. ASGE/ACG Taskforce on Quality in Endoscopy. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101:873-885.
20. Winawer SJ, Zauber AG, Fletcher RH, et al. US Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006;130:1872-1885.
21. Mysliwiec PA, Brown ML, Klabunde CN, et al. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004;141:264-271.
22. Boolchand V, Olds G, Singh J, et al. Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med. 2006;145:654-659.